These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10552994)

  • 1. The effects of the level of ampicillin resistance and the inoculum size on the in-vitro bactericidal activity of the combination of ampicillin and ciprofloxacin against high-level gentamicin-resistant strains of Enterococcus faecium.
    Tripodi MF; Rambaldi A; Sarnataro G; Ragone E; Utili R
    J Antimicrob Chemother; 1999 Nov; 44(5):719-20. PubMed ID: 10552994
    [No Abstract]   [Full Text] [Related]  

  • 2. Unorthodox antibiotic combinations including ciprofloxacin against high-level gentamicin resistant enterococci.
    Tripodi MF; Utili R; Rambaldi A; Locatelli A; Rosario P; Florio A; Ruggiero G
    J Antimicrob Chemother; 1996 Apr; 37(4):727-36. PubMed ID: 8722538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro activity of combined ampicillin and ciprofloxacin against high-level gentamicin-resistant strains of Enterococcus faecium: influence of the medium on susceptibility test results.
    Tripodi MF; Locatelli A; Rambaldi A; Rosario P; Utili R
    J Antimicrob Chemother; 1998 Jan; 41(1):139-40. PubMed ID: 9511052
    [No Abstract]   [Full Text] [Related]  

  • 4. Inconsistent bactericidal activity of triple-combination therapy with vancomycin, ampicillin, and gentamicin against vancomycin-resistant, highly ampicillin-resistant Enterococcus faecium.
    Fraimow HS; Venuti E
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1563-6. PubMed ID: 1510455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of in vitro inhibitory and bactericidal activities of daptomycin (LY 146032) and four reference antibiotics, singly and in combination, against gentamicin-susceptible and high-level-gentamicin-resistant enterococci.
    Louie A; Baltch AL; Ritz WJ; Smith RP; Asperilla M
    Chemotherapy; 1993; 39(5):302-9. PubMed ID: 8396526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multicenter trial of Enterococcus antibiotic susceptibility].
    Sidorenko SV; Rezvan SP; Grudinina SA; Krotova LA; Sterkhova GV
    Antibiot Khimioter; 1998; 43(9):9-18. PubMed ID: 9791681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple combined agar-strip test for detection of enterococcal susceptibility to ampicillin, moderate- or high-level gentamicin resistance and potential additive activity of ampicillin plus gentamicin.
    Traub WH; Leonhard B
    Chemotherapy; 1993; 39(2):82-7. PubMed ID: 8458250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel antibiotic regimens against Enterococcus faecium resistant to ampicillin, vancomycin, and gentamicin.
    Landman D; Mobarakai NK; Quale JM
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1904-8. PubMed ID: 8239604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic and molecular antibiotic resistance profile of Enterococcus faecalis and Enterococcus faecium isolated from different traditional fermented foods.
    Sánchez Valenzuela A; Lavilla Lerma L; Benomar N; Gálvez A; Pérez Pulido R; Abriouel H
    Foodborne Pathog Dis; 2013 Feb; 10(2):143-9. PubMed ID: 23259502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the synergistic interactions of levofloxacin and ampicillin against Enterococcus faecium by the checkerboard agar dilution and time-kill methods.
    Smith CE; Foleno BE; Barrett JF; Frosco MB
    Diagn Microbiol Infect Dis; 1997 Mar; 27(3):85-92. PubMed ID: 9147009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibilities of clinical isolates of vancomycin-resistant enterococci.
    Evans PA; Norden CW; Rhoads S; Deobaldia J; Silber JL
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1406. PubMed ID: 9174211
    [No Abstract]   [Full Text] [Related]  

  • 12. Modified time-kill assay against multidrug-resistant Enterococcus faecium with novel antimicrobial combinations.
    Messick CR; Rodvold KA; Pendland SL
    J Antimicrob Chemother; 1999 Dec; 44(6):831-4. PubMed ID: 10590287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The comparative in vitro activity of clinafloxacin and other antimicrobials against vancomycin-susceptible and vancomycin-resistant enterococci.
    Itokazu GS; Nathan C; Hariharan R; Kostman JR; Kabins SA; Weinstein RA
    Chemotherapy; 1996; 42(4):235-9. PubMed ID: 8804789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of the combination of trovafloxacin and other antibiotics against enterococci.
    Schick DG; Canawati HN; Montgomerie JZ
    Diagn Microbiol Infect Dis; 1997 Dec; 29(4):233-9. PubMed ID: 9458980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Enterococci as uropathogens. Frequency of isolation and sensitivity to antibacterial agents].
    Guirguitzova B; Chankova D; Zozikov B; Minkov N
    Ann Urol (Paris); 1998; 32(1):15-9. PubMed ID: 9559070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enterococcus faecium with high-level resistance to gentamicin and ampicillin: an emerging clinical problem.
    Seetulsingh P; Holliman RE
    J Antimicrob Chemother; 1994 Nov; 34(5):846-7. PubMed ID: 7706187
    [No Abstract]   [Full Text] [Related]  

  • 17. In-vitro activity of trovafloxacin against sensitive and resistant aerobic bacteria using the standard microdilution broth method and Etest.
    Dembry LM; Farrel PA; Orcutt DR; Gerrity LA; Andriole VT
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():35-42. PubMed ID: 9222068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility and molecular analysis of gentamicin-resistant enterococci.
    Chow JW; Donabedian SM; Clewell DB; Sahm DF; Zervos MJ
    Diagn Microbiol Infect Dis; 1998 Nov; 32(3):141-6. PubMed ID: 9884829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro synergistic activity of the combination of ampicillin and arbekacin against vancomycin-and high-level gentamicin-resistant Enterococcus faecium with the aph(2")-Id gene.
    Kak V; You I; Zervos MJ; Kariyama R; Kumon H; Chow JW
    Diagn Microbiol Infect Dis; 2000 Aug; 37(4):297-9. PubMed ID: 10974585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial-resistant enterococcal isolates from fluoroquinolone-naive children.
    McNeeley DF; Eckert SJ; Noel GJ
    Pediatr Infect Dis J; 2000 Jul; 19(7):675-6. PubMed ID: 10917238
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.